Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QY201 in Adolescent Subjects With Moderate to Severe Atopic Dermatitis
NCT07712536Phase 2Completed
- Sponsor
- E-nitiate
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised trial of qy201 in atopic dermatitis (AD) (2 arms), sponsored by E-nitiate. Primary endpoints: Plasma concentrations of QY201 at Day 29 and Population pharmacokinetic profiles of QY201 at Day 29. Started Jun 2025; status: completed.
02
Drugs
qy201
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07712536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712536.